X-71147745-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_181303.2(NLGN3):c.-5G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,203,276 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000011 ( 0 hom. 5 hem. )
Consequence
NLGN3
NM_181303.2 5_prime_UTR
NM_181303.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0340
Genes affected
NLGN3 (HGNC:14289): (neuroligin 3) This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. Mutations in this gene may be associated with autism and Asperger syndrome. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN3 | NM_181303.2 | c.-5G>A | 5_prime_UTR_variant | 2/8 | ENST00000358741.4 | NP_851820.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN3 | ENST00000358741 | c.-5G>A | 5_prime_UTR_variant | 2/8 | 5 | NM_181303.2 | ENSP00000351591.4 | |||
NLGN3 | ENST00000685718.1 | n.-5G>A | non_coding_transcript_exon_variant | 2/8 | ENSP00000510514.1 | |||||
NLGN3 | ENST00000685718.1 | n.-5G>A | 5_prime_UTR_variant | 2/8 | ENSP00000510514.1 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111934Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34112
GnomAD3 genomes
AF:
AC:
1
AN:
111934
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
34112
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000241 AC: 4AN: 166256Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 55052
GnomAD3 exomes
AF:
AC:
4
AN:
166256
Hom.:
AF XY:
AC XY:
0
AN XY:
55052
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000110 AC: 12AN: 1091342Hom.: 0 Cov.: 31 AF XY: 0.0000140 AC XY: 5AN XY: 358040
GnomAD4 exome
AF:
AC:
12
AN:
1091342
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
358040
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111934Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34112
GnomAD4 genome
AF:
AC:
1
AN:
111934
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
34112
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2016 | The c.-5G>A variant is located in the 5' untranslated region (5’ UTR) of the NLGN3 gene. This variant results from a G to A substitution 5 bases upstream from the first translated codon. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6436 samples with coverage at this position. This nucleotide position is not well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at